Skip to main content
. 2021 Mar 2;185(2):315–322. doi: 10.1111/bjd.19810

Table 4.

Responder rate assessed by gravimetric measurement at day 29

Placebo (n = 84) GPB 1% (n = 87) P‐value for GPB 1% vs. placebo
Sweat reduction from baseline (%)
≥ 50 29 (35) 50 (57) 0·003
≥ 75 14 (17) 28 (32) 0·011
≥ 90 8 (10) 20 (23) 0·012
HDSS improvement
≥ 1 27 (32) 41 (47) 0·045
≥ 2 10 (12) 20 (23) 0·054
HidroQoL© ≥ 4 22 (26) 52 (60) < 0·001

GPB, glycopyrronium bromide; HDSS, Hyperhidrosis Disease Severity Scale; HidroQoL, Hyperhidrosis Quality of Life Index.